96 related articles for article (PubMed ID: 1927026)
1. [Phagocyte function in uremic patients].
Ringoir S; Vanholder R
Verh K Acad Geneeskd Belg; 1991; 53(3):189-201; discussion 201-3. PubMed ID: 1927026
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Immune dysfunction in uremia.
Cohen G; Haag-Weber M; Hörl WH
Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
Ringoir SM; van Landschoot N; de Smet R
Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
[TBL] [Abstract][Full Text] [Related]
6. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
[TBL] [Abstract][Full Text] [Related]
7. Phagocytosis and neutrophil bactericidal capacity in patients with uremia.
Wierusz-Wysocka B; Wysocki H; Michta G; Wykretowicz A; Czarnecki R; Baczyk K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):589-94. PubMed ID: 6083931
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics and energy delivery to the phagocytosis-associated respiratory burst in chronic hemodialysis patients: a comparison of cefodizime and cotrimoxazole.
Vanholder R; Dagrosa EE; Van Landschoot N; Waterloos MA; Ringoir SM
Nephron; 1993; 63(1):65-72. PubMed ID: 8446254
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study.
Vanholder R; Ringoir S; Dhondt A; Hakim R
Kidney Int; 1991 Feb; 39(2):320-7. PubMed ID: 2002645
[TBL] [Abstract][Full Text] [Related]
11. Polymorphonuclear cell function and infection in dialysis.
Vanholder R; Ringoir S
Kidney Int Suppl; 1992 Oct; 38():S91-5. PubMed ID: 1405386
[TBL] [Abstract][Full Text] [Related]
12. Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis.
Vanholder R; De Smet R; Jacobs V; Van Landschoot N; Waterloos MA; Vogeleere P; Ringoir S
Nephrol Dial Transplant; 1994; 9(9):1271-8. PubMed ID: 7816288
[TBL] [Abstract][Full Text] [Related]
13. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
[TBL] [Abstract][Full Text] [Related]
14. Transport of uremic toxins through conventional hemodialysis membranes.
Jörstad S; Smeby LC; Wideröe TE; Berg KJ
Clin Nephrol; 1979 Oct; 12(4):168-73. PubMed ID: 509791
[TBL] [Abstract][Full Text] [Related]
15. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
[TBL] [Abstract][Full Text] [Related]
16. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
17. Cefodizime: enhancement of depressed phagocytosis-associated respiratory burst activity in chronic uremic patients.
Vanholder R; Ringoir S
Infection; 1992; 20 Suppl 1():S71-4. PubMed ID: 1526684
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules.
Hörl WH
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S62-71. PubMed ID: 11792764
[TBL] [Abstract][Full Text] [Related]
19. The immune status of the uremic patient: hemodialysis vs CAPD.
Schollmeyer P; Bozkurt F
Clin Nephrol; 1988; 30 Suppl 1():S37-40. PubMed ID: 3052959
[TBL] [Abstract][Full Text] [Related]
20. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
